156 related articles for article (PubMed ID: 6363838)
1. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure.
Ritschel WA; Tompson GA
Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):511-25. PubMed ID: 6363838
[No Abstract] [Full Text] [Related]
2. Saliva-plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications.
Posti J
Pharm Acta Helv; 1982; 57(3):83-92. PubMed ID: 7071071
[No Abstract] [Full Text] [Related]
3. [Drug concentrations in plasma and saliva--physiologic and pharmacokinetic considerations].
Posti J
Pharm Acta Helv; 1979; 54(7-8):191-6. PubMed ID: 515107
[No Abstract] [Full Text] [Related]
4. Is monitoring of drug in saliva reliable for bioavailability testing of a protein-bound drug? A theoretical approach.
Macheras P; Rosen A
Pharm Acta Helv; 1984; 59(2):34-6. PubMed ID: 6709662
[No Abstract] [Full Text] [Related]
5. On the distribution of drugs in saliva and blood plasma.
Feller K; le Petit G
Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):468-9. PubMed ID: 21854
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring. Pharmacokinetics.
Taylor WJ
Am J Med Technol; 1983 Aug; 49(8):557-63. PubMed ID: 6670671
[No Abstract] [Full Text] [Related]
7. [Drug content study of human saliva, bile and cerebrospinal fluid].
Scherber A; Feller K; Terhaag B; Le Petit G; Richter K
Farmakol Toksikol; 1982; 45(5):106-7. PubMed ID: 7140946
[No Abstract] [Full Text] [Related]
8. Drug and nutrient interactions.
Garabedian-Ruffalo SM; Ruffalo RL
Am Fam Physician; 1986 Feb; 33(2):165-74. PubMed ID: 3946125
[TBL] [Abstract][Full Text] [Related]
9. Primer on clinical pharmacokinetics.
Bauer LA
Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring. Pharmacokinetic and pharmacodynamic principles.
Howanitz JH; Howanitz PJ
Clin Lab Med; 1981 Sep; 1(3):467-78. PubMed ID: 7346215
[No Abstract] [Full Text] [Related]
11. [Changes in drug kinetics in liver diseases and their importance in rational pharmacotherapy].
Danysz A
Pol Tyg Lek; 1977 Dec; 32(52):2057-60. PubMed ID: 604977
[No Abstract] [Full Text] [Related]
12. Pharmacokinetic changes in critical illness.
Boucher BA; Wood GC; Swanson JM
Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
[TBL] [Abstract][Full Text] [Related]
13. [Kidney and drugs - urinary lithiasis. Pharmacokinetic glossary].
Balant L
Rev Med Suisse Romande; 1980 Nov; 100(11):949-56. PubMed ID: 7466067
[No Abstract] [Full Text] [Related]
14. Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability.
Firsov AA; Piotrovskii VK
Pharmazie; 1986 Jul; 41(7):457-65. PubMed ID: 3534896
[No Abstract] [Full Text] [Related]
15. [Pharmacokinetic aspects relevant to biopharmaceutics].
Segre G
Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
[No Abstract] [Full Text] [Related]
16. [Clinical pharmacokinetics--practical applications].
Koopmans PP; van Ginneken CA
Ned Tijdschr Geneeskd; 1986 Feb; 130(8):340-3. PubMed ID: 3960176
[No Abstract] [Full Text] [Related]
17. A small animal model utilizing salivary drug excretion for pharmacokinetic determinations.
Piraino AJ; DiGregorio GJ; Ruch EK
J Pharmacol Methods; 1980 Jan; 3(1):1-7. PubMed ID: 7374168
[No Abstract] [Full Text] [Related]
18. [When is determination of drug concentrations in plasma useful or necessary?].
Roots I
Internist (Berl); 1986 Jan; 27(1):40-52. PubMed ID: 3514516
[No Abstract] [Full Text] [Related]
19. Dependence of salivary drug concentration on salivary flow rate.
Wood JH; Flora KP; Narasimhachari N; Baker CA
Methods Find Exp Clin Pharmacol; 1982; 4(4):255-60. PubMed ID: 7121134
[TBL] [Abstract][Full Text] [Related]
20. [A pharmacokinetic function for galenics].
Dost FH
Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
